A Study of Islatravir (MK-8591) in Anti-Retroviral Therapy-Naive, Human Immunodeficiency Virus-1 Infected Participants (MK-8591-003)
Clinical trial NCT02217904 · COMPLETED
Trial details
- NCT number
- NCT02217904
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-17
- Primary completion
- 2017-05-11
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.